Lifebank Grants Stock Options to Chief Financial Officer

Lifebank Corp. ("Lifebank" or the "Company") (TSX VENTURE:LBK) announces that a
total of 100,000 incentive stock options have been granted to Jeff Charpentier,
the Company's Chief Financial Officer pursuant to the Company's Stock Option
Plan. The options are exercisable for a period of five (5) years at a price of
$0.16 per share.


About Lifebank

Started in 1996, Lifebank is a leading national company in the biomedical field.
Based at the British Columbia Institute of Technology campus in Burnaby,
Lifebank provides processing and cryogenic (ultra low temperature) storage of
umbilical cord blood stem cells for families in Canada and world-wide. A full
description of the advantages and benefits of storing the stem cells from an
infant's umbilical cord can be found on the Company's website at
www.lifebank.com.


On January 21, 2004, Lifebank received official accreditation from the
international organization AABB and was the first accredited cord blood stem
cell bank in Canada. In February 2010, celebrating another milestone in Cellular
Therapy and Transplant Medicine, Lifebank has achieved the globally recognized
FACT accreditation.